O. Alpdogan and M. R. Van-den-brink, IL-7 and IL-15: therapeutic cytokines for immunodeficiency, Trends Immunol, vol.26, pp.56-64, 2005.

K. H. Grabstein, J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan et al., Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor, Science, vol.264, pp.965-968, 1994.

S. R. Sprang, F. Bazan, and J. , Cytokine structural taxonomy and mechanisms of receptor engagement, Curr Opin Struct Biol, vol.3, pp.815-827, 1993.

J. D. Burton, R. N. Bamford, C. Peters, A. J. Grant, G. Kurys et al., A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells, Proc Natl Acad Sci, vol.91, pp.4935-4939, 1994.

W. E. Carson, J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh et al., Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor, J Exp Med, vol.180, pp.1395-1403, 1994.

J. A. Johnston, C. M. Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan et al., Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15, Proc Natl Acad Sci, vol.92, pp.8705-8709, 1995.

T. Miyazaki, Z. J. Liu, A. Kawahara, Y. Minami, K. Yamada et al., Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation, Cell, vol.81, pp.223-231, 1995.

D. M. Anderson, S. Kumaki, M. Ahdieh, J. Bertles, M. Tometsko et al., Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes, J Biol Chem, vol.270, pp.29862-29869, 1995.

Y. Minami, T. Kono, T. Miyazaki, and T. Taniguchi, The IL-2 receptor complex: its structure, function, and target genes, Annu Rev Immunol, vol.11, pp.245-268, 1993.

J. G. Giri, D. M. Anderson, S. Kumaki, L. S. Park, and K. H. Grabstein, Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2, J Leukocyte Biol, vol.57, pp.763-766, 1995.

P. Lehours, S. Raher, S. Dubois, J. Guo, A. Godard et al., Subunit structure of the high and low affinity human interleukin-15 receptors, Eur Cytokine Netw, vol.11, pp.207-215, 2000.

D. G. Norman, P. N. Barlow, M. Baron, A. J. Day, R. B. Sim et al., Three-dimensional structure of a complement control protein module in solution, J Mol Biol, vol.219, pp.717-725, 1991.

M. Rickert, X. Wang, M. J. Boulanger, N. Goriatcheva, and K. C. Garcia, The structure of interleukin-2 complexed with its alpha receptor, Science, vol.308, pp.1477-1480, 2005.

S. Dubois, F. Magrangeas, P. Lehours, S. Raher, J. Bernard et al., Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression, J Biol Chem, vol.274, pp.26978-26984, 1999.

S. S. Bulfone-pau, E. Bulanova, T. Pohl, V. Budagian, H. Durkop et al., Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15R alpha chain, FASEB J, vol.13, pp.1575-1585, 1999.

R. Pereno, J. Giron-michel, A. Gaggero, E. Cazes, R. Meazza et al., IL-15/IL-15R alpha intracellular trafficking in human melanoma cells and signal transduction through the IL-15R alpha, Oncogene, vol.19, pp.5153-5162, 2000.

E. Bulanova, V. Budagian, T. Pohl, H. Krause, H. Durkop et al., Bulfone-Paus S. The IL-15R alpha chain signals through association with Syk in human B cells, J Immunol, vol.167, pp.6292-6302, 2001.

J. G. Giri, M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein et al., Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15, EMBO J, vol.13, pp.2822-2830, 1994.

D. M. Willerford, J. Chen, J. A. Ferry, L. Davidson, A. Ma et al., Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment, Immunity, vol.3, pp.521-530, 1995.

J. P. Lodolce, P. R. Burkett, D. L. Boone, M. Chien, and A. Ma, T cell-independent interleukin 15R alpha signals are required for bystander proliferation, J Exp Med, vol.194, pp.1187-1194, 2001.

M. K. Kennedy, M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney et al., Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice, J Exp Med, vol.191, pp.771-780, 2000.

T. A. Fehniger and M. A. Caligiuri, Interleukin 15: biology and relevance to human disease, Blood, vol.97, pp.14-32, 2001.

T. A. Fehniger, M. A. Cooper, and M. A. Caligiuri, Interleukin-2 and interleukin-15: immunotherapy for cancer, Cytokine Growth Factor Rev, vol.13, pp.169-183, 2002.

D. K. Pettit, T. P. Bonnert, J. Eisenman, S. Srinivasan, R. Paxton et al., Structure-function studies of interleukin 15 using site-specific mutagenesis, polyethylene glycol conjugation, and homology modeling, J Biol Chem, vol.272, pp.2312-2318, 1997.

L. Collins, W. H. Tsien, C. Seals, J. Hakimi, D. Weber et al., Identification of specific residues of human interleukin 2 that affect binding to the 70-K d a subunit (p70) of the interleukin 2 receptor, Proc Natl Acad Sci, vol.85, pp.7709-7713, 1988.

P. Bamborough, C. J. Hedgecock, and W. G. Richards, The interleukin-2 and interleukin-4 receptors studied by molecular modelling, Structure, vol.2, pp.839-851, 1994.

J. Bernard, C. Harb, E. Mortier, A. Quemener, R. H. Meloen et al., Identification of an interleukin-15 alpha receptor-binding site on human interleukin-15, J Biol Chem, vol.279, pp.24313-24322, 2004.

S. M. Zurawski, F. Vega, J. Doyle, E. L. Huyghe, B. Flaherty et al., Definition and spatial location of mouse interleukin-2 residues that interact with its heterotrimeric receptor, EMBO J, vol.12, pp.5113-5119, 1993.

A. B. Shanafelt, Y. Lin, M. C. Shanafelt, C. P. Forte, N. Dubois-stringfellow et al., A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo, Nat Biotechnol, vol.18, pp.1197-1202, 2000.

K. Sauve, M. Nachman, C. Spence, P. Bailon, E. Campbell et al., Localization in human interleukin 2 of the binding site to the alpha chain (p55) of the interleukin 2 receptor, Proc Natl Acad Sci, vol.88, pp.4636-4640, 1991.

E. Mortier, A. Quemener, P. Vusio, I. Lorenzen, Y. Boublik et al., Soluble IL-15R alpha sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma: hyper-agonist IL-15-IL-15R alpha fusion proteins, J Biol Chem, vol.281, pp.1612-1619, 2006.

A. Sali and T. L. Blundell, Comparative protein modelling by satisfaction of spatial restraints, J Mol Biol, vol.234, pp.779-815, 1993.

D. Eisenberg, R. Luthy, and J. U. Bowie, VERIFY3D: assessment of protein models with three-dimensional profiles, Methods Enzymol, vol.277, pp.396-404, 1997.

M. J. Sippl, Recognition of errors in three-dimensional structures of proteins, Proteins, vol.17, pp.355-362, 1993.

R. A. Laskowski, M. W. Macarthur, D. S. Moss, and J. M. Thornton, PRO-CHECK: a program to check the stereochemical quality of protein structures, J Appl Crystallogr, vol.26, pp.283-291, 1993.

A. A. Canutescu, A. A. Shelenkov, and R. L. Dunbrack, A graph-theory algorithm for rapid protein side-chain prediction, Protein Sci, vol.12, pp.2001-2014, 2003.

B. R. Brooks, B. D. Olafson, D. J. States, S. Swaminathan, and M. Karplus, CHARMM: A program for macromolecular energy, minimization, and dynamics calculations, J Comput Chem, vol.4, pp.187-217, 1983.

D. M. Engelman and T. A. Steitz, The spontaneous insertion of proteins into and across membranes: the helical hairpin hypothesis, Cell, vol.23, pp.411-422, 1981.

D. W. Ritchie and G. J. Kemp, Protein docking using spherical polar Fourier correlations, Proteins, vol.39, pp.178-194, 2000.
URL : https://hal.archives-ouvertes.fr/inria-00434273

H. A. Gabb, R. M. Jackson, and M. J. Sternberg, Modelling protein docking using shape complementarity, electrostatics and biochemical information, J Mol Biol, vol.272, pp.106-120, 1997.

J. W. Slootstra, W. C. Puijk, G. J. Ligtvoet, J. P. Langeveld, and R. H. Meloen, Structural aspects of antibody-antigen interaction revealed through small random peptide libraries, Mol Divers, vol.1, pp.87-96, 1996.

J. Marks-konczalik, S. Dubois, J. M. Losi, H. Sabzevari, N. Yamada et al., IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice, Proc Natl Acad Sci, vol.97, pp.11445-11450, 2000.

P. J. Fraker and J. C. Speck, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a, 6a-diphrenylglycoluril, Biochem Biophys Res Commun, vol.80, pp.849-857, 1978.

F. Tejedor and J. P. Ballesta, Iodination of biological samples without loss of functional activity, Anal Biochem, vol.127, pp.143-149, 1982.

S. Jones and J. M. Thornton, Principles of protein-protein interactions, Proc Natl Acad Sci, vol.93, pp.13-20, 1996.

S. Dubois, J. Mariner, T. A. Waldmann, and Y. Tagaya, IL-15R alpha recycles and presents IL-15 in trans to neighboring cells, Immunity, vol.17, pp.537-547, 2002.

X. Wang, M. Rickert, and K. C. Garcia, Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gamma c receptors, Science, vol.310, pp.1159-1163, 2005.

R. J. Robb, C. M. Rusk, and M. P. Neeper, Structure-function relationships for the interleukin 2 receptor: location of ligand and antibody binding sites on the Tac receptor chain by mutational analysis, Proc Natl Acad Sci, vol.85, pp.5654-5658, 1988.